Frequently Asked Questions

Conference Speakers

Cultural Speakers

Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.

At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:

- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Dr. Second Speaker Name
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
View Registration Info
Speakers

Speakers (5191)

Saturday, 11 September 2021 08:09

Mozziyar Etemadi

Written by
Saturday, 11 September 2021 08:03

Gerry Hanna

Written by
Professor Gerry Hanna is a consultant Clinical Oncologist and Clinical Director at the Northern Ireland Cancer Centre, Belfast and recent past director of Radiation Oncology at the Peter MacCallum Cancer Centre, Melbourne. Prof Hanna’s research interests are the use of PET/CT in radiotherapy planning for lung cancer, mechanisms of radiotherapy resistance, technical radiotherapy, stereotactic ablative radiotherapy and systemic therapy and immunotherapy combinations with radiotherapy. He is the chief investigator of the International Atomic Energy Agency’s “PERTAIN” study and previous co-chief Investigator of the CONCORDE study, a UK study of novel agents in combination with radiotherapy in the treatment of lung cancer. He is the Principle investigator on the ACRF funded Radiation Therapy / Immunotherapy Program at Peter Mac examining how best to harness the synergy between radiotherapy and immunotherapy, and in particular CAR-T cell therapy. He is a TMG member for the UK’s HALT, SARON and CONFIRM studies. He is a member of TROG and a past member of the Australian National Particle Therapy working group. Away from work he enjoys cycling, good music and pretending to play the piano.
Friday, 10 September 2021 13:58

John Skadow

Written by
Since 2015, John has been responsible for all financial planning and daily financial management for the IASLC. One of his favorite aspects of the job is working with the association’s inspiring members and dedicated staff. John’s previous experience includes working in the natural resources industry and the nonprofit sector; he is also a licensed CPA. When not at work, John can usually be found adventuring outside in the Rocky Mountains.
Wednesday, 08 September 2021 08:41

Eric Nadler

Written by
Eric Nadler, MD, MPP, is a medical oncologist serving as Co-chair of Thoracic-Head and Neck Research at the Texas Oncology-Baylor Charles A. Sammons Cancer Center in Dallas, Texas, and Medical Director of US Oncology Health Informatics and Internet Technology. In addition, he is a principal investigator of the Patient-Centered Communications Initiative at the National Cancer Institute. Dr Nadler earned his joint medical degree and master’s degree in public policy from Harvard Medical School and Harvard University’s Kennedy School of Government in Boston, Massachusetts. He completed his residency in internal medicine at Brigham and Women’s Hospital and his fellowship in medical oncology at the Dana-Farber Cancer Institute, also in Boston. Dr Nadler is a member of the American Society of Clinical Oncology and the Texas Medical Association.
Thursday, 02 September 2021 08:45

Neil Love

Written by
Thursday, 02 September 2021 08:45

Justin Gainor

Written by
Monday, 30 August 2021 10:47

Bonnie Addario

Written by
Monday, 30 August 2021 10:47

Jamal Khader

Written by
Monday, 30 August 2021 10:47

Kristin Ito

Written by
Monday, 30 August 2021 10:47

Paz Vellanki

Written by
Page 1 of 371